Evidence map›Paper›PMID 20057941›Full record

ArticleInternational journal of molecular sciences2009

Effects of acrylamide on the activity and structure of human brain creatine kinase.

Qing Sheng, He-Chang Zou, Zhi-Rong Lü, Fei Zou, Yong-Doo Park, Yong-Bin Yan, Shan-Jing Yao

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Qing ShengDepartment of Chemical and Biochemical Engineering, Zhejiang University, Hangzhou 310027, China.
He-Chang ZouYangtze Delta Region Institute of Tsinghua University, Jiaxing 314050, China.
Zhi-Rong LüDepartment of Environmental Health, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou 510515, China.
Fei ZouDepartment of Environmental Health, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou 510515, China.
Yong-Doo ParkYangtze Delta Region Institute of Tsinghua University, Jiaxing 314050, China.
Yong-Bin YanState Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China.
Shan-Jing YaoDepartment of Chemical and Biochemical Engineering, Zhejiang University, Hangzhou 310027, China.
Tsinghua University · CNSouthern Medical University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acrylamide is widely used worldwide in industry and it can also be produced by the cooking and processing of foods. It is harmful to human beings, and human brain CK (HBCK) has been proposed to be one of the important targets of acrylamide. In this research, we studied the effects of acrylamide on HBCK activity, structure and the potential binding sites. Compared to CKs from rabbit, HBCK was fully inactivated at several-fold lower concentrations of acrylamide, and exhibited distinct properties upon acrylamide-induced inactivation and structural changes. The binding sites of acrylamide were located at the cleft between the N- and C-terminal domains of CK, and Glu232 was one of the key binding residues. The effects of acrylamide on CK were proposed to be isoenzyme- and species-specific, and the underlying molecular mechanisms were discussed.

Indexed as

AcrylamideAnimalsBinding SitesBrainCreatine Kinase, BB FormHumansKineticsMolecular Docking SimulationProtein BindingProtein Structure, TertiaryRabbitsAcrylamideCreatine Kinase, BB Formacrylamidedocking simulationhuman brain creatine kinaseinactivation

Identifiers

PMID20057941
PMCPMC2790104
OpenAlexW1969640238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.